Associations of luteal phase changes in vagally mediated heart rate variability with premenstrual emotional changes.

IF 2.4 3区 医学 Q2 OBSTETRICS & GYNECOLOGY
Katja M Schmalenberger, Tory A Eisenlohr-Moul, Marc N Jarczok, Ekaterina Schneider, Jordan C Barone, Julian F Thayer, Beate Ditzen
{"title":"Associations of luteal phase changes in vagally mediated heart rate variability with premenstrual emotional changes.","authors":"Katja M Schmalenberger, Tory A Eisenlohr-Moul, Marc N Jarczok, Ekaterina Schneider, Jordan C Barone, Julian F Thayer, Beate Ditzen","doi":"10.1186/s12905-024-03273-y","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>A recent meta-analysis revealed that vagally mediated heart rate variability (vmHRV; a biomarker of emotion regulation capacity) significantly decreases in the luteal phase of the menstrual cycle. As two follow-up studies suggest, these vmHRV decreases are driven primarily by increased luteal progesterone (P4). However, analyses also revealed significant interindividual differences in vmHRV reactivity to the cycle, which is in line with longstanding evidence for interindividual differences in mood sensitivity to the cycle. The present study begins to investigate whether these interindividual differences in vmHRV cyclicity can explain who is at higher risk of showing premenstrual emotional changes. We expected a greater degree of midluteal vmHRV decrease to be predictive of a greater premenstrual increase in negative affect.</p><p><strong>Methods: </strong>We conducted an observational study with a naturally cycling community sample (N = 31, M = 26.03 years). Over a span of six weeks, participants completed (a) daily ratings of negative affect and (b) counterbalanced lab visits in their ovulatory, midluteal, and perimenstrual phases. Lab visits were scheduled based on positive ovulation tests and included assessments of baseline vmHRV and salivary ovarian steroid levels.</p><p><strong>Results: </strong>In line with previous research, multilevel models suggest that most of the sample shows ovulatory-to-midluteal vmHRV decreases which, however, were not associated with premenstrual emotional changes. Interestingly, it was only the subgroup with luteal increases in vmHRV whose negative affect markedly worsened premenstrually and improved postmenstrually.</p><p><strong>Conclusion: </strong>The present study begins to investigate cyclical changes in vmHRV as a potential biomarker of mood sensitivity to the menstrual cycle. The results demonstrate a higher level of complexity in these associations than initially expected, given that only atypical midluteal increases in vmHRV are associated with greater premenstrual negative affect. Potential underlying mechanisms are discussed, among those the possibility that luteal vmHRV increases index compensatory efforts to regulate emotion in those with greater premenstrual negative affect. However, future studies with larger and clinical samples and more granular vmHRV assessments should build on these findings and further explore associations between vmHRV cyclicity and menstrually related mood changes.</p>","PeriodicalId":9204,"journal":{"name":"BMC Women's Health","volume":null,"pages":null},"PeriodicalIF":2.4000,"publicationDate":"2024-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11308668/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Women's Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12905-024-03273-y","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: A recent meta-analysis revealed that vagally mediated heart rate variability (vmHRV; a biomarker of emotion regulation capacity) significantly decreases in the luteal phase of the menstrual cycle. As two follow-up studies suggest, these vmHRV decreases are driven primarily by increased luteal progesterone (P4). However, analyses also revealed significant interindividual differences in vmHRV reactivity to the cycle, which is in line with longstanding evidence for interindividual differences in mood sensitivity to the cycle. The present study begins to investigate whether these interindividual differences in vmHRV cyclicity can explain who is at higher risk of showing premenstrual emotional changes. We expected a greater degree of midluteal vmHRV decrease to be predictive of a greater premenstrual increase in negative affect.

Methods: We conducted an observational study with a naturally cycling community sample (N = 31, M = 26.03 years). Over a span of six weeks, participants completed (a) daily ratings of negative affect and (b) counterbalanced lab visits in their ovulatory, midluteal, and perimenstrual phases. Lab visits were scheduled based on positive ovulation tests and included assessments of baseline vmHRV and salivary ovarian steroid levels.

Results: In line with previous research, multilevel models suggest that most of the sample shows ovulatory-to-midluteal vmHRV decreases which, however, were not associated with premenstrual emotional changes. Interestingly, it was only the subgroup with luteal increases in vmHRV whose negative affect markedly worsened premenstrually and improved postmenstrually.

Conclusion: The present study begins to investigate cyclical changes in vmHRV as a potential biomarker of mood sensitivity to the menstrual cycle. The results demonstrate a higher level of complexity in these associations than initially expected, given that only atypical midluteal increases in vmHRV are associated with greater premenstrual negative affect. Potential underlying mechanisms are discussed, among those the possibility that luteal vmHRV increases index compensatory efforts to regulate emotion in those with greater premenstrual negative affect. However, future studies with larger and clinical samples and more granular vmHRV assessments should build on these findings and further explore associations between vmHRV cyclicity and menstrually related mood changes.

迷走神经介导的心率变异性的黄体期变化与经前情绪变化的关联。
背景最近的一项荟萃分析显示,在月经周期的黄体期,迷走神经介导的心率变异性(vmHRV,一种情绪调节能力的生物标志物)明显下降。两项后续研究表明,vmHRV 的下降主要是由黄体孕酮(P4)的增加引起的。然而,分析还显示,个体间对月经周期的vmHRV反应性存在显著差异,这与长期以来有证据表明个体间对月经周期的情绪敏感性存在差异是一致的。本研究开始探讨 vmHRV 周期性的个体间差异是否能解释哪些人更容易出现经前情绪变化。我们预计,黄体中期 vmHRV 下降的程度越大,预示着经前负面情绪增加的程度越大:我们对自然骑行的社区样本(N = 31,M = 26.03 岁)进行了观察研究。在为期六周的时间里,参与者完成了(a)每日负面情绪评分和(b)排卵期、黄体中期和围经期的平衡实验室检查。实验室检查根据阳性排卵测试安排,包括基线 vmHRV 和唾液卵巢类固醇水平的评估:与之前的研究结果一致,多层次模型表明,大多数样本的排卵期至黄体中期vmHRV都会下降,但这与经前情绪变化无关。有趣的是,只有黄体期 vmHRV 上升的亚组,其负面情绪在经前明显恶化,而在经后有所改善:本研究开始研究 vmHRV 的周期性变化,将其作为情绪对月经周期敏感性的潜在生物标志物。研究结果表明,这些关联的复杂程度高于最初的预期,因为只有黄体中期vmHRV的非典型增加才与经前更大的负面情绪有关。研究讨论了潜在的内在机制,其中包括黄体期 vmHRV 增加可能是经前负面情绪较重的人调节情绪的补偿性努力。不过,未来的研究应在这些发现的基础上,通过更大规模的临床样本和更精细的vmHRV评估,进一步探讨vmHRV周期性与月经相关情绪变化之间的关联。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BMC Women's Health
BMC Women's Health OBSTETRICS & GYNECOLOGY-
CiteScore
3.40
自引率
4.00%
发文量
444
审稿时长
>12 weeks
期刊介绍: BMC Women''s Health is an open access, peer-reviewed journal that considers articles on all aspects of the health and wellbeing of adolescent girls and women, with a particular focus on the physical, mental, and emotional health of women in developed and developing nations. The journal welcomes submissions on women''s public health issues, health behaviours, breast cancer, gynecological diseases, mental health and health promotion.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信